Bumper Offer - Urjas oil Just @ Rs. 1
Levepsy 250 Tablet (15) is a prescription drug, available for use as Tablet. It is typically used for the treatment of Epilepsy. Levepsy 250 Tablet (15) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Levepsy 250 Tablet (15). The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Levepsy 250 Tablet (15) include Fatigue, Headache, Drowsiness. Some other side effects of Levepsy 250 Tablet (15) have been listed ahead. These side effects of Levepsy 250 Tablet (15) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Levepsy 250 Tablet (15)'s effect during pregnancy is Moderate and Mild while nursing. Warnings related to Levepsy 250 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Levepsy 250 Tablet (15) are listed in the contraindications section below.
Drug reaction of Levepsy 250 Tablet (15) with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Levepsy 250 Tablet (15) is considered not safe while driving, and is not addictive.
Levepsy 250 Tablet (15) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levepsy 250 Tablet (15) is used -
Moderate
Mild
Common
Is the use of Levepsy 250 Tablet (15) safe for pregnant women?
Levepsy may have some side effects during pregnancy. Pregnant women should discontinue the use of Levepsy, and talk to their doctor, if they notice any discomfort.
Is the use of Levepsy 250 Tablet (15) safe during breastfeeding?
Side effects of Levepsy for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Levepsy 250 Tablet (15) on the Kidneys?
Levepsy has very mild side effects on the kidneys.
What is the effect of Levepsy 250 Tablet (15) on the Liver?
Levepsy may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Levepsy 250 Tablet (15) on the Heart?
Levepsy is completely safe for the heart.
Levepsy 250 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levepsy 250 Tablet (15) unless your doctor advises you to do so -
Is this Levepsy 250 Tablet (15) habit forming or addictive?
Levepsy 250 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levepsy 250 Tablet (15) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Levepsy 250 Tablet (15) only on doctor's advice.
Is it able to treat mental disorders?
Levepsy 250 Tablet (15) has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Levepsy 250 Tablet (15)
Taking Levepsy 250 Tablet (15) with food does not harm your health.
Interaction between Alcohol and Levepsy 250 Tablet (15)
Taking Levepsy 250 Tablet (15) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
